Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neurotoxicity Syndromes 1Breast Neoplasms 1

Interventions

Paclitaxel 5Vincristine 3Oxaliplatin 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Carboplatin 3Amifostine 3xaliproden 2glucarpidase 2Taxes 2Radiotherapy 2Psychiatric Rehabilitation 2Procarbazine 2Methotrexate 2Magnesium Sulfate 2Leucovorin 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2Calcium Gluconate 22,2'-dithiodiethanesulfonic acid 2neurotropin 1glutamic acid diethyl ester 1eribulin 1axicabtagene ciloleucel 1Vitamin E 1Trastuzumab 1Thioctic Acid 1Thalidomide 1Tadalafil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurotoxicity Syndromes × Ginkgo Extract × Clear all
NCT00046891 2016-07-06

EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
226 enrolled 12 charts
Breast

Breast Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡